Senior insider sale
Chief Human Resources Officer at ALNYLAM PHARMACEUTICALS, INC. — senior position signals high conviction
$731.7K
2.29K shares
What this filing means
MCLAUGHLIN MELISSA plans to sell 2.29K shares of ALNYLAM PHARMACEUTICALS, INC. valued at approximately $731.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/6/2026ACC: 0001969223-26-000425
Officer· Chief Human Resources Officer
Since Mar 2026
2.29K
Shares to sell
$731.7K
Approx. market value
2.29K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Award
N/A
4/1/2026
2.29KTotal acquired2.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Stock Award N/A | 2.29K | — |
| Total | 2.29K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.29K
Market value
$731.7K
4/6/2026
Total
Units
2.29K
Value
$731.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/6/2026 | 2.29K | $731.7K | NASDAQ | Planned |
| Total | 2.29K | $731.7K | ||